Navigation Links
Express Scripts Research Shows Prescription Drug Utilization Declines for Payers of Workers' Compensation
Date:4/22/2013

ST. LOUIS, April 22, 2013 /PRNewswire/ -- Express Scripts' (NASDAQ: ESRX) industry-leading prescription management programs drove down utilization of prescription drugs for workers' compensation payers last year even though overall drug trend rose, according to new research released today in the Express Scripts 2012 Workers' Compensation Drug Trend Report.

(Logo:  http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO)

Narcotic analgesics, which once again accounted for the highest spend among therapy classes in workers' compensation, saw utilization decline 2.7 percent. OxyContin®, which accounted for nearly 10 percent of the total drug spend, had a 6.1 percent drop in utilization, although at $132.50, it still represents the highest average cost per user.

Overall trend — a combination of spending on drugs and utilization of drugs — increased 2.9 percent in 2012, reversing two years of declines, driven primarily by a 10 percent increase in cost per user for antidepressants and dermatologicals, such as Lidoderm™, Flector™ and Voltaren™. Availability of new products or new product indications in the two classes greatly affected trend.

Tim Pokorney , pharmacist, and clinical director of workers' compensation at Express Scripts, noted that the findings demonstrate the need for effective prescription-drug management programs for workers' compensation payers.

"Payers need innovative solutions that help them drive the use of clinically equivalent, cost-effective generics that can help rein in their overall pharmacy spending," Pokorney said. "Express Scripts is uniquely positioned to offer payers better solutions by bringing together our complementary capabilities of the behavioral sciences, clinical specialization and actionable data."

Programs that help control utilization include Oral Fentanyl Intervention and Long-Acting Narcotics outreach to physicians. Express Scripts also offers step therapy, narcotics education for injured workers and physicians, Drug Utilization Review, Physician Peer-to-Peer, and formulary management programs.

One product that helps manage trend for clients is a communication program that encourages injured workers to use lower-cost generic equivalents. The product is based on the findings of an Express Scripts research pilot which demonstrated how injured workers who received a letter explaining how their prescription drug choices could help control the rising cost of healthcare were 60% more likely to choose a generic equivalent.

Preventing Abuse to Drive Down Costs

Express Scripts offers a comprehensive first-of-its-kind fraud, waste and abuse program for workers' compensation payers to better manage narcotic utilization. Narcotics comprise more than a third of the cost and utilization in workers' compensation, and given the potential for misuse and abuse, payers need a focused approach to managing their use.

"Our fraud program combines our unique data analytics with clinical expertise and investigative services in a proven solution that increases savings for payers and safety for injured workers by reducing narcotics misuse and abuse," Pokorney said

In the U.S., prescription drug overdoses result in 1.2 million emergency room visits and more than 15,000 deaths each year — more than cocaine and heroin combined.

"We look for patterns of behavioral red flags to find cases that may otherwise be missed," he said. "We leverage thousands of tips each year and constantly refine our algorithm and data identification process as we continue to enhance our offering."

The full Express Scripts 2012 Workers' Compensation Drug Trend Report is available at  http://www.express-scripts.com/services/workerscompensation/.

About Express Scripts

Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients — employers, health plans, unions and government health programs — we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities — behavioral sciences, clinical specialization and actionable data — to create Health Decision ScienceSM, our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

MEDIA CONTACT:
Riddhi Trivedi-St. Clair
Office: 314-684-6665
Rtrivedi-st.clair@express-scripts.com


'/>"/>
SOURCE Express Scripts
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Express Scripts Recommends Rejection of TRC Capitals "Mini-Tender" Offer
2. Express Scripts Study Reveals Keys to Controlling Specialty Drug Costs
3. Express Scripts to Present at Upcoming Conferences
4. Generex Touts Pipeline Potential of Antigen Express Subsidiary
5. Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine
6. FCS Express Compatible with Life Technologies Tali Image Based Cytometer
7. Express Scripts Holding Company Announces Fourth Quarter 2012 Earnings Conference Call
8. Suture Express Files Antitrust Lawsuit Against Cardinal Health and Owens & Minor
9. Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
10. Express Scripts Reports Third Quarter Results
11. The Growing Cost of Aging: Express Scripts Study Shows Medication Use for Normal Aging Conditions Overtakes Costs of Treating Most Chronic Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology:
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):